Effect of Different Types and Dosages of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a) Levels: A Network Meta-analysis
Journal of cardiovascular pharmacology（2023）
Key words
lipoprotein(a), proprotein convertase subtilisin, kexin type 9 inhibitors, network meta-analysis, randomized controlled trials
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined